![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Establishing darunavir dosing recommendations
in treatment-naïve and treatment-experienced pediatric patients
|
|
|
Reported by Jules Levin
14th Intl Workshop on Clinical Pharmacology in HIV April 22-24 2013 Amsterdam
Thomas N Kakuda,1 Anne Brochot,2 Tom van de Casteele,3
Magda Opsomer,3 Frank Tomaka1
1Janssen Research & Development LLC, Titusville, NJ, USA; 2Janssen Research & Development, Beerse, Belgium; 3Janssen Infectious Diseases BVBA, Beerse, Belgium
![Pharm1.gif](../images/052613/052613-5/Pharm1.gif)
![Pharm2.gif](../images/052613/052613-5/Pharm2.gif)
![Pharm3.gif](../images/052613/052613-5/Pharm3.gif)
![Pharm4.gif](../images/052613/052613-5/Pharm4.gif)
![Pharm5.gif](../images/052613/052613-5/Pharm5.gif)
![Pharm6.gif](../images/052613/052613-5/Pharm6.gif)
![Pharm7.gif](../images/052613/052613-5/Pharm7.gif)
![Pharm8.gif](../images/052613/052613-5/Pharm8.gif)
![Pharm9.gif](../images/052613/052613-5/Pharm9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|